Charles River Laboratories International (CRL) Deferred Taxes (2016 - 2025)
Charles River Laboratories International has reported Deferred Taxes over the past 17 years, most recently at -$60.2 million for Q4 2025.
- Quarterly results put Deferred Taxes at -$60.2 million for Q4 2025, down 45.2% from a year ago — trailing twelve months through Dec 2025 was -$75.3 million (down 11.66% YoY), and the annual figure for FY2025 was -$75.3 million, down 11.66%.
- Deferred Taxes for Q4 2025 was -$60.2 million at Charles River Laboratories International, down from $25.9 million in the prior quarter.
- Over the last five years, Deferred Taxes for CRL hit a ceiling of $25.9 million in Q3 2025 and a floor of -$60.2 million in Q4 2025.
- Median Deferred Taxes over the past 5 years was -$11.6 million (2022), compared with a mean of -$12.7 million.
- Biggest five-year swings in Deferred Taxes: surged 477.25% in 2021 and later plummeted 1829.18% in 2025.
- Charles River Laboratories International's Deferred Taxes stood at -$10.2 million in 2021, then rose by 6.71% to -$9.6 million in 2022, then crashed by 136.92% to -$22.7 million in 2023, then tumbled by 82.94% to -$41.4 million in 2024, then plummeted by 45.2% to -$60.2 million in 2025.
- The last three reported values for Deferred Taxes were -$60.2 million (Q4 2025), $25.9 million (Q3 2025), and -$22.0 million (Q2 2025) per Business Quant data.